Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-07

FDA Approved: ETODOLAC — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved the original ANDA for etodolac from Amneal Pharmaceuticals NY LLC, enabling the marketing of a generic etodolac product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etodolac (Etodolac)

Snippet

ORIG AP for ETODOLAC (ETODOLAC)